Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijing Sun

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Cancer|September 11, 2010
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcoholMarissa Albert, Matthew V Kiefer, Weijing Sun, et al.
Journal of Oncology|June 13, 2019
Clinical Outcome of Ampullary Carcinoma: Single Cancer Center ExperienceMohammed Al-Jumayli, Amna Batool, Akshay Middiniti, et al.
Cancer|March 23, 2011
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center studyMatthew V Kiefer, Marissa Albert, Madeline McNally, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 9, 2004
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcomeKirti Shetty, Kate Timmins, Colleen Brensinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 daysWeijing Sun, James P Stevenson, Maryann L Gallagher, et al.
Journal of Clinical Medicine|August 23, 2020
Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective StudyAnwaar Saeed, Hannah Hildebrand, Robin Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 daysJames P Stevenson, Weijing Sun, Maryann Gallagher, et al.
Frontiers in Oncology|April 5, 2021
Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic ReviewChengliang Huang, Meizhang Li, Ben Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I trial of combretastatin a-4 phosphate with carboplatinJoshua H Bilenker, Keith T Flaherty, Mark Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinomaGregory L Beatty, Drew A Torigian, E Gabriela Chiorean, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Cancer|September 11, 2010
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcoholMarissa Albert, Matthew V Kiefer, Weijing Sun, et al.
Journal of Oncology|June 13, 2019
Clinical Outcome of Ampullary Carcinoma: Single Cancer Center ExperienceMohammed Al-Jumayli, Amna Batool, Akshay Middiniti, et al.
Cancer|March 23, 2011
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center studyMatthew V Kiefer, Marissa Albert, Madeline McNally, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 9, 2004
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcomeKirti Shetty, Kate Timmins, Colleen Brensinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 daysWeijing Sun, James P Stevenson, Maryann L Gallagher, et al.
Journal of Clinical Medicine|August 23, 2020
Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective StudyAnwaar Saeed, Hannah Hildebrand, Robin Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 daysJames P Stevenson, Weijing Sun, Maryann Gallagher, et al.
Frontiers in Oncology|April 5, 2021
Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic ReviewChengliang Huang, Meizhang Li, Ben Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I trial of combretastatin a-4 phosphate with carboplatinJoshua H Bilenker, Keith T Flaherty, Mark Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinomaGregory L Beatty, Drew A Torigian, E Gabriela Chiorean, et al.
Pageof 14